tiprankstipranks
Trending News
More News >
Genetic Technologies Limited (AU:GTG)
:GTG

Genetic Technologies (GTG) Price & Analysis

Compare
6 Followers

GTG Stock Chart & Stats


Financials

GTG FAQ

What was Genetic Technologies Limited’s price range in the past 12 months?
Genetic Technologies Limited lowest share price was AU$0.04 and its highest was AU$0.09 in the past 12 months.
    What is Genetic Technologies Limited’s market cap?
    Genetic Technologies Limited’s market cap is AU$5.67M.
      When is Genetic Technologies Limited’s upcoming earnings report date?
      Genetic Technologies Limited’s upcoming earnings report date is Aug 28, 2025 which is in 71 days.
        How were Genetic Technologies Limited’s earnings last quarter?
        Currently, no data Available
        Is Genetic Technologies Limited overvalued?
        According to Wall Street analysts Genetic Technologies Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Genetic Technologies Limited pay dividends?
          Genetic Technologies Limited does not currently pay dividends.
          What is Genetic Technologies Limited’s EPS estimate?
          Genetic Technologies Limited’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Genetic Technologies Limited have?
          Genetic Technologies Limited has 1,335,422,500 shares outstanding.
            What happened to Genetic Technologies Limited’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Genetic Technologies Limited?
            Currently, no hedge funds are holding shares in AU:GTG

            Genetic Technologies Stock Smart Score

            5
            Neutral
            1
            2
            3
            4
            5
            6
            7
            8
            9
            10

            Fundamentals

            Return on Equity
            -181.97%
            Trailing 12-Months
            Asset Growth
            -58.22%
            Trailing 12-Months

            Company Description

            Genetic Technologies Limited

            Genetic Technologies Limited, a molecular diagnostics company, provides predictive genetic testing and risk assessment tools to help physicians manage people's health in the United States, Canada, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. It operates in two segments, EasyDNA and GeneType/Corporate. The company offers BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It also markets BREVAGenplus to healthcare professionals in breast health care and imaging centers, as well as to obstetricians/gynecologists and breast cancer risk assessment specialists, such as breast surgeons. In addition, the company offers various cancer risk assessment tests under the GeneType for Colorectal Cancer and GeneType for Breast Cancer brand names; and develops other risk assessment tests across a range of diseases, which include colorectal cancer, ovarian cancer, prostate cancer, coronary artery, and type 2 diabetes. Further, it offers genetic testing services, including medical, animal, forensic, and plant testing. The company has research and collaboration agreements with the University of Melbourne, Translational Genomics Research Institute, Memorial Sloan Kettering New York Cambridge University, the Ohio State University, and Shivom. Genetic Technologies Limited was incorporated in 1987 and is headquartered in Fitzroy, Australia.
            Similar Stocks
            Company
            Price & Change
            Follow
            BCAL Diagnostics Limited
            Rhythm Biosciences Ltd.
            Lumos Diagnostics Holdings Ltd.
            Imagion Biosystems Ltd.
            Inoviq Ltd
            Popular Stocks
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis